Follow
Melanie Jannaway
Melanie Jannaway
Verified email at astrazeneca.com
Title
Cited by
Cited by
Year
A disintegrin and metalloproteinase 15-mediated glycocalyx shedding contributes to vascular leakage during inflammation
X Yang, JE Meegan, M Jannaway, DC Coleman, SY Yuan
Cardiovascular research 114 (13), 1752-1763, 2018
832018
Citrullinated histone 3 causes endothelial barrier dysfunction
JE Meegan, X Yang, RS Beard Jr, M Jannaway, V Chatterjee, ...
Biochemical and biophysical research communications 503 (3), 1498-1502, 2018
782018
Neutrophil‐mediated vascular barrier injury: role of neutrophil extracellular traps
JE Meegan, X Yang, DC Coleman, M Jannaway, SY Yuan
Microcirculation 24 (3), e12352, 2017
672017
Resolvin E1, resolvin D1 and resolvin D2 inhibit constriction of rat thoracic aorta and human pulmonary artery induced by the thromboxane mimetic U46619
M Jannaway, C Torrens, JA Warner, AP Sampson
British Journal of Pharmacology 175 (7), 1100-1108, 2018
402018
Thrombin-cleaved syndecan-3/-4 ectodomain fragments mediate endothelial barrier dysfunction
M Jannaway, X Yang, JE Meegan, DC Coleman, SY Yuan
PLoS One 14 (5), e0214737, 2019
332019
Lymphatic valves and lymph flow in cancer-related lymphedema
D Iyer, M Jannaway, Y Yang, J P. Scallan
Cancers 12 (8), 2297, 2020
312020
VE-cadherin and vesicles differentially regulate lymphatic vascular permeability to solutes of various sizes
M Jannaway, JP Scallan
Frontiers in Physiology 12, 687563, 2021
182021
VEGFR3 is required for button junction formation in lymphatic vessels
M Jannaway, D Iyer, DM Mastrogiacomo, K Li, DC Sung, Y Yang, ...
Cell reports 42 (7), 2023
62023
Sinusoidal and lymphatic vessel growth is controlled by reciprocal VEGF-C–CDH5 inhibition
DC Sung, M Chen, MH Dominguez, A Mahadevan, X Chen, J Yang, ...
Nature cardiovascular research 1 (11), 1006-1021, 2022
42022
Lymphatic vascular permeability
JP Scallan, M Jannaway
Cold Spring Harbor Perspectives in Medicine 12 (8), a041274, 2022
42022
P Scallan J
D Iyer, M Jannaway, Y Yang
Lymphatic valves and lymph flow in cancer-related lymphedema. Cancers (Basel …, 2020
42020
Neutrophil extracellular traps contribute to endothelial barrier dysfunction during sepsis
JE Meegan, RS Beard Jr, X Yang, JJ Reynolds, DC Coleman, ...
The FASEB Journal 31, 679.1-679.1, 2017
22017
Lymphatic Vascular Permeability Determined from Direct Measurements of Solute Flux
M Jannaway, JP Scallan
Vascular Hyperpermeability: Methods and Protocols, 21-37, 2023
2023
A Disintegrin and Metalloproteinase 15‐Mediated Glycocalyx Disruption Contributes to Vascular Leakage During Septic Injury
X Yang, JE Meegan, M Jannaway, DC Coleman, SR Ospina, SY Yuan
The FASEB Journal 32, 846.1-846.1, 2018
2018
Thrombin Cleavage of Endothelial Glycocalyx Syndecan‐4 Ectodomain in Human Lung Vasculature
M Jannaway, X Yang, JE Meegan, SR Ospina, DC Coleman, SY Yuan
The FASEB Journal 32, 706.1-706.1, 2018
2018
Citrullinated Histone 3 Contributes to Endothelial Barrier Dysfunction During Sepsis
J Meegan, X Yang, M Jannaway, V Chatterjee, SY Yuan
The FASEB Journal 32, 574.2-574.2, 2018
2018
CLEAVED SYNDECAN-2 AND-4 MODULATE ENDOTHELIAL BARRIER RESISTANCE
M Jannaway, Y Yang, JE Meegan, SY Yuan
SHOCK 47 (6), 109-109, 2017
2017
ADAM15 CONTRIBUTES TO CD44 CLEAVAGE IN ENDOTHELIAL CELLS DURING INFLAMMATION
X Yang, JE Meegan, M Jannaway, SY Yuan
SHOCK 47 (6), 109-109, 2017
2017
Inflammation‐Induced Syndecan Shedding Contributes to Endothelial Barrier Dysfunction
M Jannaway, X Yang, JE Meegan, SY Yuan
The FASEB Journal 31, 834.7-834.7, 2017
2017
ADAM15‐mediated glycocalyx injury contributes to vascular barrier dysfunction during inflammation
X Yang, JE Meegan, M Jannaway, SY Yuan
The FASEB Journal 31, 834.1-834.1, 2017
2017
The system can't perform the operation now. Try again later.
Articles 1–20